Your browser doesn't support javascript.
loading
Tumour predisposition and cancer syndromes as models to study gene-environment interactions.
Carbone, Michele; Arron, Sarah T; Beutler, Bruce; Bononi, Angela; Cavenee, Webster; Cleaver, James E; Croce, Carlo M; D'Andrea, Alan; Foulkes, William D; Gaudino, Giovanni; Groden, Joanna L; Henske, Elizabeth P; Hickson, Ian D; Hwang, Paul M; Kolodner, Richard D; Mak, Tak W; Malkin, David; Monnat, Raymond J; Novelli, Flavia; Pass, Harvey I; Petrini, John H; Schmidt, Laura S; Yang, Haining.
Afiliação
  • Carbone M; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI, USA. mcarbone@cc.hawaii.edu.
  • Arron ST; STA, JEC, Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA.
  • Beutler B; Center for Genetic Host Defense, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Bononi A; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI, USA.
  • Cavenee W; Ludwig Institute, University of California, San Diego, San Diego, CA, USA.
  • Cleaver JE; STA, JEC, Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA.
  • Croce CM; Department of Cancer Biology and Genetics, Ohio State University, Columbus, OH, USA.
  • D'Andrea A; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Foulkes WD; Department of Human Genetics, McGill University, Montreal, QC, Canada.
  • Gaudino G; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI, USA.
  • Groden JL; VC Research, University of Illinois, Chicago, IL, USA.
  • Henske EP; Center for LAM Research, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Hickson ID; Center for Chromosome Stability, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Hwang PM; Center for Healthy Aging, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Kolodner RD; Cardiovascular Branch, National Institutes of Health, Bethesda, MD, USA.
  • Mak TW; Ludwig Institute, University of California, San Diego, San Diego, CA, USA.
  • Malkin D; Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada.
  • Monnat RJ; Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
  • Novelli F; Department Pathology, Washington University, Seattle, WA, USA.
  • Pass HI; Department of Genome Science, Washington University, Seattle, WA, USA.
  • Petrini JH; Thoracic Oncology, University of Hawaii Cancer Center, Honolulu, HI, USA.
  • Schmidt LS; Department of Cardiovascular Surgery, New York University, New York, NY, USA.
  • Yang H; Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nat Rev Cancer ; 20(9): 533-549, 2020 09.
Article em En | MEDLINE | ID: mdl-32472073
Cell division and organismal development are exquisitely orchestrated and regulated processes. The dysregulation of the molecular mechanisms underlying these processes may cause cancer, a consequence of cell-intrinsic and/or cell-extrinsic events. Cellular DNA can be damaged by spontaneous hydrolysis, reactive oxygen species, aberrant cellular metabolism or other perturbations that cause DNA damage. Moreover, several environmental factors may damage the DNA, alter cellular metabolism or affect the ability of cells to interact with their microenvironment. While some environmental factors are well established as carcinogens, there remains a large knowledge gap of others owing to the difficulty in identifying them because of the typically long interval between carcinogen exposure and cancer diagnosis. DNA damage increases in cells harbouring mutations that impair their ability to correctly repair the DNA. Tumour predisposition syndromes in which cancers arise at an accelerated rate and in different organs - the equivalent of a sensitized background - provide a unique opportunity to examine how gene-environment interactions influence cancer risk when the initiating genetic defect responsible for malignancy is known. Understanding the molecular processes that are altered by specific germline mutations, environmental exposures and related mechanisms that promote cancer will allow the design of novel and effective preventive and therapeutic strategies.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / Interação Gene-Ambiente / Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / Interação Gene-Ambiente / Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article